Physician profile
Nitin Kumar Sekhri
NPI 1992958060
$3,298.68
in general payments reported to CMS, 2019-2025
20 companies · $589 in 2025
The $589 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $75.46 · 2020: $89.40 · 2021: $381 · 2022: $1,355 · 2023: $325 · 2024: $484 · 2025: $589.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,398.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,398.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $631.12 | 2021-2025 | Kyphon Express II Kyphopak Tray, Intellis Adaptivestim, Osteocool Rf Ablation System |
| Eli Lilly and Company | $575.00 | 2022 | |
| Boston Scientific Corporation | $530.90 | 2019-2025 | Wavewriter Alpha Prime 16, Intracept, General - Pain Management |
| Abbott Laboratories | $372.58 | 2020-2025 | Proclaim |
| Nevro Corp. | $162.43 | 2022-2024 | Senza |
| Orthofix Medical, INC. | $150.06 | 2022 | |
| Si-Bone, INC. | $143.27 | 2021-2025 | |
| Globus Medical, INC. | $132.52 | 2024 | Excelsiusgps Robotic Navigation System, Tlif |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $123.65 | 2022 | |
| Grt US Holding, INC. | $108.39 | 2022 | |
| Abbvie INC. | $96.38 | 2023 | Botox |
| Nalu Medical, INC. | $50.39 | 2021-2022 | |
| Averitas Pharma INC. | $46.93 | 2023 | Qutenza |
| Saluda Medical Americas, INC. | $35.85 | 2025 | Evoke |
| Arbor Pharmaceuticals, INC. | $34.13 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Curonix LLC | $27.82 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Collegium Pharmaceutical, INC. | $21.43 | 2025 | Belbuca |
| Spr Therapeutics, INC | $20.06 | 2024 | Sprint Pns System |
| Azurity Pharmaceuticals, INC. | $18.99 | 2023 | Gliadel |
| Medtronic USA, INC. | $16.78 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nitin Sekhri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.